Written and sourced by Vincent Wesley Couey, RxGrab founder. Updated .
As an Amazon Associate I earn from qualifying purchases.
Manufacturers run programs that provide brand-name medicine at no cost to people who qualify, and many people who might qualify never apply. The programs exist, the medication is shipped to you or your prescriber, and the main things between you and a $0 prescription are knowing which program fits your drug and finishing the paperwork.
We built this guide to close that gap. Below, we cover the seven largest manufacturer PAPs, the 2026 federal poverty levels, a step-by-step application walkthrough, and what to do if you get denied. If you are paying hundreds or thousands per month for brand-name drugs, this may be the single most valuable page you read this year. For the broader picture, see our complete PAP overview or our 7 strategies to save on prescriptions without insurance.
A patient assistance program is a manufacturer-run initiative that provides brand-name prescription drugs at no cost to patients who meet income and insurance requirements. These are not coupons. They are not discount cards. The manufacturer ships the actual medication - the same pills or injections you would get at CVS or Walgreens - directly to you or your doctor's office. You pay nothing.
Why do pharmaceutical companies do this? Several reasons work in their favor. Free medication for low-income patients generates tax deductions, produces goodwill, and keeps patients on their brand-name drug rather than switching to a competitor or generic. It also lets manufacturers maintain high list prices for everyone else. Whatever the motivations, the outcome for qualifying patients is real: zero-dollar prescriptions on drugs that cost $500 to $15,000 per month at retail.
PAPs are distinct from manufacturer copay cards, which reduce out-of-pocket costs for commercially insured patients, and from non-profit foundation grants, which help with copays for specific diseases. PAPs are for patients who cannot afford the drug at all - typically because they are uninsured, underinsured, or their plan does not cover the medication. You can search for programs by drug name using OmniRx's patient assistance finder. For more context on navigating government assistance programs alongside PAPs, GrantProbe's guide to government assistance covers the broader landscape.
The federal poverty level (FPL) is the baseline for nearly every PAP. Programs set their cutoff as a multiple of FPL, commonly somewhere between 200% and 500%, and the multiple differs by program and sometimes by drug. Here are the 2026 federal poverty levels (HHS, 48 contiguous states and D.C.) at several multiples, so you can convert a program's percentage into dollars:
| Household Size | 100% FPL | 200% FPL | 300% FPL | 400% FPL |
|---|---|---|---|---|
| 1 person | $15,960 | $31,920 | $47,880 | $63,840 |
| 2 people | $21,640 | $43,280 | $64,920 | $86,560 |
| 3 people | $27,320 | $54,640 | $81,960 | $109,280 |
| 4 people | $33,000 | $66,000 | $99,000 | $132,000 |
| 5 people | $38,680 | $77,360 | $116,040 | $154,720 |
Read the higher columns carefully. A multiple of 300% or 400% is not a poverty-level income: for a family of four it is $99,000 or $132,000. If you have been assuming you earn too much, find the program's own multiple on its page and check it against this table. Source: HHS ASPE poverty guidelines ($15,960 for one person, plus $5,680 for each additional person).
Limits are not uniform across programs, and a program can change its limit or its list of covered drugs from one year to the next. The table below points to each major manufacturer's own page, where the current limit and covered drugs are stated.
These seven programs cover the majority of expensive brand-name drugs prescribed in the United States. Each one provides medications at zero cost to approved patients.
| Manufacturer | Program Name | Where to read the current rules | Key Drugs Covered | Application Method |
|---|---|---|---|---|
| Pfizer | Pfizer RxPathways | Pfizer RxPathways | Eliquis, Ibrance, Xeljanz, Prevnar | Online, fax, mail |
| Eli Lilly | Lilly Cares | Lilly Cares, on Lilly's site | Insulin (Humalog, Basaglar), Verzenio (insulin $35 and free routes) | Online, fax, mail |
| Novo Nordisk | Novo Nordisk PAP | NovoCare Patient Assistance Program; for Ozempic, NovoCare lists uninsured patients only, with income at or below 200% of the federal poverty level (page read October 20, 2026) | Ozempic and other Novo Nordisk medicines (NovoCare lists the ones still covered in 2026) | Online only |
| AstraZeneca | AZ&Me Prescription Savings | AZ&Me, on AstraZeneca's site | Symbicort, Fasenra, Lynparza, Tagrisso (Farxiga: closed to new patients 1 May 2026) | Online, fax, mail |
| Johnson & Johnson | J&J Patient Assistance | Johnson & Johnson Patient Assistance Foundation | Xarelto, Stelara, Tremfya, Invega, Darzalex | Online, fax |
| Merck | Merck Helps | Merck Helps | Keytruda, Januvia, Janumet, Isentress, Gardasil | Online, fax, mail |
| AbbVie | myAbbVie Assist | myAbbVie Assist, on AbbVie's site | Humira, Skyrizi, Rinvoq, Viekira, Imbruvica | Online, fax |
Notice that the limits are not uniform, and some programs apply different limits by drug or by insurance status. For most patients the eligibility question comes down to an income check against the FPL table above, using the multiple on the program's own page.
Before you apply, compare the drug's retail price at your local pharmacy using our pharmacy price finder tool. Knowing the retail cost helps you understand exactly how much a PAP approval would save you - and gives you a fallback price if you need to pay out of pocket while your application is processed.
The savings from approval can be large. One example we can price from Novo Nordisk's own pages (read October 30, 2026): NovoCare Pharmacy sells the Ozempic 0.25, 0.5 or 1 mg pen to a cash-paying patient for $349 a month, so $4,188 over a year, against $0 for a patient the Patient Assistance Program approves. For other brand drugs, ask the program or your pharmacy for the current cash price to see what approval would save you; list prices change often, so we do not print them here.
| Drug | Condition | Monthly self-pay price | Annual self-pay cost | PAP cost |
|---|---|---|---|---|
| Ozempic (0.25, 0.5 or 1 mg) | Type 2 Diabetes | $349 | $4,188 | $0 |
When the drug costs hundreds or thousands of dollars a month, the paperwork and the wait for approval are small next to the saving. Use a discount card or manufacturer copay card as a bridge while you wait.
The process is consistent across nearly all manufacturer PAPs. Follow these eight steps:
Three databases cover nearly every PAP available in the United States. All three are free to use:
The most comprehensive resource. Search by drug name to find manufacturer PAPs, copay assistance cards, state pharmaceutical programs, and non-profit foundation grants. NeedyMeds also maintains a toll-free helpline (1-800-503-6897) staffed by trained counselors who can walk you through applications.
A database maintained by Volunteers in Health Care that organizes programs by drug and manufacturer. Each listing includes direct links to application forms, eligibility requirements, and contact numbers. The interface is simpler than NeedyMeds, which makes it useful for quick lookups.
The pharmaceutical industry's own search tool, covering all programs from PhRMA member companies. Answer a few eligibility screening questions and it returns matching programs with application links. Because it is maintained by the industry trade group, it tends to be the most up-to-date source for program changes.
We recommend starting with NeedyMeds for the broadest results, then cross-referencing with the manufacturer's program page directly. If you are researching multiple options beyond PAPs, our discount card comparison and cheapest pharmacy guide cover faster alternatives for generic drugs.
Here is an important distinction: manufacturer PAPs almost exclusively cover brand-name drugs. Generic medications are rarely included because they are already cheap enough to obtain through other channels.
If you need a generic drug and cannot afford it, your best options are:
For brand-name drugs where no generic exists, PAPs are the most powerful savings tool available. For generics, the options above will almost always get you to a price under $10/month. For a holistic view of supplement alternatives that may reduce your medication burden, Health Britannica explores evidence-based supplement options.
| Savings Method | Best For | Time to Savings | Typical Savings |
|---|---|---|---|
| Patient Assistance Programs | Expensive brand drugs, income within the program's limit | Varies by program | 100% (free) |
| Manufacturer copay cards | Brand drugs, commercially insured patients | Same day | 50-95% |
| GoodRx / SingleCare | Any drug at any retail pharmacy | Same day | 20-85% |
| Cost Plus Drugs | Generic maintenance medications | 5-7 business days (mail order, standard) | 50-90% |
| Walmart $4 list | Common generics, same-day need | Same day | 80-95% |
| Non-profit foundation grants | Copay assistance for specific diseases | 1-3 weeks | Varies (copay covered) |
The decision tree is straightforward. If you take an expensive brand-name drug and your income is within the program's limit, apply for the manufacturer's PAP immediately. While you wait for approval, use a discount card or manufacturer copay card as a bridge. If you take generics, skip PAPs entirely and go straight to Cost Plus, Walmart, or a discount card. Our insurance vs. cash price analysis explains when paying cash with a discount card actually beats using your insurance.
PAP applications are not difficult, but they are detail-sensitive. These are the most frequent reasons for denial and how to prevent each one:
If you are denied, you can almost always appeal within 30 days. The appeal should include the missing or corrected documentation, plus a brief letter explaining your situation. Many patients who are denied on first attempt are approved on appeal with more complete paperwork.
Beyond manufacturer programs, several non-profit organizations provide copay assistance, medication grants, and financial support for specific conditions:
These foundations are especially valuable for Medicare patients who are excluded from manufacturer PAPs. Apply to multiple foundations simultaneously - each covers different conditions and drugs, and there is no penalty for holding grants from more than one source.
Understanding the timeline helps you plan and avoid gaps in your medication supply:
| Stage | Timeframe | What Happens |
|---|---|---|
| Application submitted | Day 1 | Manufacturer confirms receipt (usually by mail or email) |
| Review period | Days 2-14 | Manufacturer verifies income, insurance status, and prescriber info |
| Decision | Days 14-28 | Approval or denial letter sent. If approved, medication ships immediately. |
| First shipment | Days 18-35 | 90-day supply arrives at your home or doctor's office |
| Renewal | Month 6-12 | Reapply before current enrollment expires to avoid supply gaps |
If you will run out of your current supply before the PAP decision arrives, call the manufacturer's helpline and ask about bridge programs. Most large manufacturers can provide a 30-day emergency supply while your application is processed. Your doctor may also be able to provide samples to cover the gap.
Patient assistance programs (PAPs) are manufacturer-sponsored programs that provide brand-name prescription medications at no cost to qualifying patients. Eligibility typically requires U.S. residency, household income within the program's limit (set as a multiple of the federal poverty level, $15,960 for one person in 2026), and either no insurance or insurance that does not cover the specific medication, depending on the program. A prescribing physician must sign the application confirming medical necessity.
Processing time varies by program, often a few weeks from submission to decision. Online and faxed applications process faster than mailed ones. If approved, medications ship within a few days of the decision, and you will receive a 90-day supply. If you need medication urgently while waiting, contact the manufacturer about bridge supplies or ask your doctor for samples.
Many manufacturer PAPs exclude patients with government insurance. However, alternatives exist. Medicare patients should look into the Medicare Extra Help (Low-Income Subsidy) program, which can reduce Part D costs to no more than $12.65 per prescription in 2026 ($5.10 for generics). Non-profit foundations like the PAN Foundation and HealthWell Foundation provide copay assistance specifically for Medicare beneficiaries. Some manufacturers also run separate Medicare-specific assistance programs.
You typically need your most recent federal tax return or two recent pay stubs as proof of income, proof of insurance status (your insurance card or a letter confirming you are uninsured), a valid prescription from your doctor, and the completed application form signed by your prescribing physician. Some programs also request a brief written statement of financial hardship.
You can typically appeal within 30 days. The most common fixes are providing additional income documentation, including records of medical expenses that lower your effective income, or obtaining a stronger medical necessity letter from your doctor. If the denial is final, alternatives include manufacturer copay cards (for insured patients), discount programs like pharmacy discount cards, or transparent pharmacies like Cost Plus Drugs. Non-profit foundations may also help cover costs for specific conditions.
We have not started sending yet. Join the list and we will only email when we do.
Prescription prices in the United States are set through a documented chain of list prices, pharmacy benefit contracts and federal programs, and the sources below are the primary public records of how that chain works. They are linked so a reader can check a claim here without taking this page's word for it.
This page describes how prescription pricing and discount programs work. It is not medical advice, and what a given person pays depends on their own plan, pharmacy and prescriber.